ruthenium has been researched along with Adenocarcinoma, Basal Cell in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 5 (31.25) | 24.3611 |
2020's | 3 (18.75) | 2.80 |
Authors | Studies |
---|---|
Batista, AA; Cerqueira, IH; Costa, AR; de Araujo-Neto, JH; De Grandis, RA; Demidoff, FC; Guedes, APM; Marques, WG; Moraes, CAF; Netto, CD; Pavan, FR; Resende, FA; Sampaio, NZ | 1 |
Bodman-Smith, K; Daher, CF; Khnayzer, RS; Mansour, N | 1 |
Brustolin, L; Dalla Pozza, M; Fregona, D; Gaiddon, C; Nardon, C; Orvain, C; Pettenuzzo, N | 1 |
Dömötör, O; Enyedy, ÉA; Grgurić-Šipka, S; May, NV; Poljarević, JM; Savić, AR; Spengler, G; Tamás Gál, G | 1 |
Cierniak, A; Komarnicka, UK; Kołoczek, P; Kyzioł, A; Płotek, M; Sebastian, V; Skórska-Stania, A | 1 |
Able, S; Carlisle, R; Gill, MR; Jarman, PJ; Menon, JU; Owen, J; Skaripa-Koukelli, I; Thomas, JA; Vallis, KA | 1 |
Ciudad, C; Florindo, P; Helena Garcia, M; Morais, TS; Moreno, V; Noe, V; Piedade, MF | 1 |
Chen, L; Chen, T; He, QY; Liu, J; Liu, Y; Yang, X; Yang, Y; Zheng, W | 1 |
Castonguay, A; Doucet, C; Juhas, M; Maysinger, D | 1 |
Bergamo, A; Cocchietto, M; DiGiovine, S; Garbisa, S; Pezzoni, G; Sartor, L; Sava, G; Soranzo, M; Turrin, C; Vita, F; Zabucchi, G; Zorzet, S | 1 |
Romanowska-Dixon, B | 1 |
Alessio, E; Bergamo, A; Golobic, A; Pecanac, M; Sava, G; Serli, B; Turel, I | 1 |
Alroy, J; Cohen, SM; Goyal, V; Heaney, JA; Klauber, GT; Ucci, AA | 1 |
Atkins, HL; Brill, AB; Guglielmi, G; Matsui, K; Oster, ZH; Pellettieri, ML; Persson, BR; Richards, P; Som, P; Srivastava, SC | 1 |
Anghileri, LJ | 1 |
Berger, MR; Garzon, FT; Keppler, BK; Schmähl, D | 1 |
16 other study(ies) available for ruthenium and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Caco-2 Cells; Carcinoma; Cell Line, Tumor; Coordination Complexes; Humans; Ligands; Male; Phenanthrolines; Reactive Oxygen Species; Ruthenium | 2022 |
A photoactivatable Ru (II) complex bearing 2,9-diphenyl-1,10-phenanthroline: A potent chemotherapeutic drug inducing apoptosis in triple negative human breast adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Phenanthrolines; Photochemical Processes; Ruthenium; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2021 |
Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Proliferation; Coordination Complexes; Gold; Humans; Ruthenium; Stomach Neoplasms; Thiocarbamates; Tumor Cells, Cultured | 2021 |
Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Coordination Complexes; Crystallography, X-Ray; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Stability; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Molecular Conformation; Picolinic Acids; Ruthenium; Solubility; Toluene | 2018 |
Polymeric micelle-mediated delivery of half-sandwich ruthenium(II) complexes with phosphanes derived from fluoroloquinolones for lung adenocarcinoma treatment.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cisplatin; Coordination Complexes; DNA Fragmentation; Drug Carriers; Fluoroquinolones; Humans; Inhibitory Concentration 50; Lung Neoplasms; Micelles; Nanoparticles; Phosphines; Poloxalene; Ruthenium | 2018 |
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; ErbB Receptors; Esophageal Neoplasms; Female; Humans; Indium Radioisotopes; Mice; Mice, Inbred BALB C; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radiation-Sensitizing Agents; Ruthenium | 2018 |
Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Crystallography, X-Ray; DNA; Humans; Ligands; Microscopy, Atomic Force; Organometallic Compounds; Pancreatic Neoplasms; Ruthenium | 2009 |
Ruthenium methylimidazole complexes induced apoptosis in lung cancer A549 cells through intrinsic mitochondrial pathway.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Coordination Complexes; Gene Expression; Humans; Imidazoles; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Phenanthrolines; Proto-Oncogene Proteins c-bcl-2; Ruthenium; Signal Transduction | 2012 |
New ruthenium(II)-letrozole complexes as anticancer therapeutics.
Topics: Adenine; Adenocarcinoma; Antineoplastic Agents; Aromatase Inhibitors; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Curcumin; Drug Interactions; Drug Screening Assays, Antitumor; Female; Glioblastoma; Humans; Letrozole; Nitriles; Ruthenium; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2012 |
Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Adhesion; Cell Division; Collagen; Collagen Type IV; Dimethyl Sulfoxide; Drug Combinations; Female; Humans; Kidney; Laminin; Lung; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Neoplasm Invasiveness; Organometallic Compounds; Proteoglycans; Ruthenium; Ruthenium Compounds; Tumor Cells, Cultured | 2003 |
[Treatment of intraocular metastatic tumors].
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoid Tumor; Combined Modality Therapy; Eye Enucleation; Eye Neoplasms; Female; Fluorescein Angiography; Humans; Hyperthermia, Induced; Laser Coagulation; Laser Therapy; Lung Neoplasms; Male; Middle Aged; Ruthenium; Treatment Outcome | 2003 |
Solution, solid state and biological characterization of ruthenium(III)-DMSO complexes with purine base derivatives.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Adhesion Molecules; Crystallography, X-Ray; Dimethyl Sulfoxide; Hydrogen Bonding; Mice; Organometallic Compounds; Purines; Ruthenium; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured | 2004 |
Cell surface coat of human and rat bladder urothelium. I. Ruthenium-red studies in non-neoplastic and neoplastic cells.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Animals; Carcinoma, Transitional Cell; Cell Membrane; Child; Child, Preschool; Humans; Infant; Male; Microscopy, Electron; Microvilli; Middle Aged; Mucous Membrane; Papilloma; Rats; Ruthenium; Ruthenium Red; Staining and Labeling; Urinary Bladder; Urinary Bladder Neoplasms | 1983 |
97Ru-transferrin uptake in tumor and abscess.
Topics: Abscess; Adenocarcinoma; Animals; Gallium Radioisotopes; Glioma; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Rabbits; Radioisotopes; Ruthenium; Transferrin; Turpentine | 1983 |
The in vivo inhibition of tumor growth by ruthenium red: its relationship with the metabolism of calcium in the tumor.
Topics: Adenocarcinoma; Animals; Biological Transport; Body Weight; Calcium; Intracellular Fluid; Leukemia, Experimental; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Magnesium; Melanoma; Mice; Mice, Inbred AKR; Mice, Inbred C3H; Mice, Inbred C57BL; Microsomes; Mitochondria; Neoplasms, Experimental; Phosphorus; Ruthenium; Sarcoma, Experimental | 1975 |
Comparative antitumor activity of ruthenium derivatives with 5'-deoxy-5-fluorouridine in chemically induced colorectal tumors in SD rats.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Dimethylnitrosamine; Floxuridine; Imidazoles; Male; Organometallic Compounds; Rats; Rats, Inbred Strains; Rectal Neoplasms; Ruthenium | 1987 |